Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective-Reference-Cited by-同舟云学术

Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective

Published:2017-02-20 Issue:6 Volume:35 Page:587-590
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Fotopoulou Christina¹,Sehouli Jalid¹,Aletti Giovanni¹,Harter Philipp¹,Mahner Sven¹,Querleu Denis¹,Chiva Luis¹,Gabra Hani¹,Colombo Nicoletta¹,du Bois Andreas¹

Affiliation:

1. Christina Fotopoulou, Imperial College London, London, United Kingdom; Jalid Sehouli, Charité Medical University of Berlin, Berlin, Germany; Giovanni Aletti, European Institute of Oncology, Milan, Italy; Philipp Harter, Kliniken Essen Mitte, Essen, Germany; Sven Mahner, Ludwig-Maximilians-University, Munich, Germany; Denis Querleu, Institut Bergonié, Bordeaux, France; Luis Chiva, Clínica Universidad de Navarra, Navarra, Spain; Hani Gabra, Imperial College London, London, United Kingdom; Nicoletta Colombo...

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.71.0723

Reference30 articles.

1. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline

2. Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

3. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

4. Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy

5. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. The role of neoadjuvant chemotherapy in advanced ovarian cancer: The right treatment to the right patient – Ensuring optimal outcomes in advanced ovarian cancer;BJOG: An International Journal of Obstetrics & Gynaecology;2023-11-08

3. Evolutions in the management of advanced ovarian cancer;Gynecology and Pelvic Medicine;2023-06

4. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis;Gynecologic Oncology;2022-12

5. Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research;Frontiers in Oncology;2022-03-25